PVD, or peripheral vascular disease, is a condition where blood vessels outside the heart and brain become narrowed or blocked, reducing blood flow to the limbs. It most commonly affects the legs and feet. PVD is actually an umbrella term that covers both peripheral artery disease (PAD), caused by fatty plaque buildup in the arteries, and venous disease, which involves problems with the veins. Most of the time, when doctors talk about PVD, they’re referring to the arterial side.
How PVD Develops
The underlying process in most PVD cases is atherosclerosis, the same type of plaque buildup that causes heart attacks and strokes. It starts when the inner lining of a blood vessel becomes damaged or inflamed. Over time, cholesterol, fat, and other substances accumulate along the vessel wall, forming a plaque that progressively narrows the artery. Inflammatory pathways accelerate this process, making the plaque larger and sometimes unstable.
Symptoms typically don’t appear until an artery is narrowed by more than 70%. At that point, there’s not enough blood flow to meet the demands of the surrounding tissue, especially during physical activity. The legs are the most common site because they’re far from the heart and require strong blood flow during walking or exercise.
Stages and Symptoms
PVD progresses through distinct stages, and many people in the earliest stage have no symptoms at all. They may have partial blockages that haven’t yet become severe enough to cause problems during daily life.
The hallmark symptom of PVD is claudication: a cramping, aching, or tired feeling in the calves, thighs, or buttocks that comes on with walking and goes away within minutes of resting. The Fontaine classification system breaks this into mild claudication (pain after walking more than about 200 meters) and moderate claudication (pain after less than 200 meters). How far you can walk before the pain starts gives doctors a rough measure of severity.
As PVD worsens, pain begins occurring at rest, particularly at night when the legs are elevated. This is called critical limb ischemia, the most serious chronic stage. At this point, the blood supply is so limited that the tissue starts to break down, potentially leading to non-healing ulcers, skin changes, or gangrene. Symptoms of critical limb ischemia are typically present for at least two weeks before diagnosis.
Risk Factors
Smoking is the single strongest risk factor for PVD, and its connection to peripheral artery disease is even more powerful than its link to heart disease or stroke. A Johns Hopkins study found that people who smoked more than a pack a day had 5.4 times the risk of developing PVD compared to never-smokers. By contrast, the same level of smoking raised coronary heart disease risk by 2.4 times and stroke risk by 1.9 times. Heavy long-term smokers (more than 40 pack-years) still carried about four times the risk.
Quitting helps substantially, but recovery is slow. Within 5 to 9 years of quitting, PVD risk drops by about 57%, a faster decline than what’s seen for heart disease or stroke. However, it takes a full 30 years of not smoking before the risk returns to the level of someone who never smoked at all.
Diabetes is the other major driver. High blood sugar damages blood vessel walls over time, accelerating plaque formation and making existing blockages worse. Other risk factors include high blood pressure, high cholesterol, obesity, kidney disease, and a family history of vascular problems. Age is also a factor, with PVD becoming significantly more common after 50.
How PVD Is Diagnosed
The primary screening tool for PVD is the ankle-brachial index, or ABI. It’s a simple, painless test that compares the blood pressure measured at your ankle to the blood pressure in your arm. A healthy ratio falls between 1.00 and 1.40. Values between 0.91 and 0.99 are considered borderline, while 0.41 to 0.90 indicates mild to moderate disease. An ABI of 0.40 or lower signals severe PVD.
Values above 1.40 can also be abnormal. They suggest the arteries have become stiff and difficult to compress, which is common in people with diabetes or advanced kidney disease. In those cases, additional tests are needed to get an accurate picture. When doctors suspect the disease has progressed enough to require a procedure, imaging studies such as angiography can map exactly where and how severe the blockages are.
Exercise as First-Line Treatment
For people with claudication, supervised exercise therapy is the recommended first-line treatment. The standard program involves walking sessions of 30 to 60 minutes, at least three times per week, for a minimum of 12 weeks. Medicare covers up to 36 sessions over that period. The goal is to walk until the cramping or discomfort starts, rest until it subsides, then walk again. Over time, this progressively extends the distance you can cover before symptoms appear.
This approach works because it trains the muscles to use oxygen more efficiently and encourages the development of smaller collateral blood vessels that can partially bypass the blocked areas. It’s not a cure, but the improvement in walking ability and quality of life can be significant enough to delay or avoid the need for a procedure.
Medical and Surgical Treatment
Beyond exercise, PVD management focuses on controlling the underlying cardiovascular risk. This typically involves cholesterol-lowering medications to slow plaque growth, blood pressure management, and blood-thinning or antiplatelet therapy to reduce the chance of clots forming at the site of narrowed arteries. These treatments aren’t just protecting the legs. People with PVD have a high risk of heart attack and stroke because the same plaque process is usually happening throughout the body.
When lifestyle changes and medication aren’t enough, or when the disease has progressed to critical limb ischemia with rest pain, ulcers, or tissue death, invasive procedures become necessary. The two main options are endovascular therapy (using a catheter threaded through a blood vessel to open the blockage with a balloon or stent) and surgical bypass (rerouting blood flow around the blocked section using a graft). The choice depends on where the blockage is, how extensive it is, and the patient’s overall health. For shorter, simpler blockages, catheter-based approaches are preferred. For longer, more complex ones, surgery tends to produce better long-term results.
Complications and Long-Term Outlook
The most feared complication of advanced PVD is amputation. When blood flow becomes too limited to sustain the tissue and no procedure can restore it, removing part of the affected limb may be the only option to prevent life-threatening infection. The mortality risk following a major amputation for vascular disease is substantial. Five-year mortality rates average around 18% in recent data, though older literature reports rates as high as 60%. Amputations above the knee carry worse outcomes than those below the knee, with five-year mortality rates of roughly 24% versus 17%.
Importantly, the vascular disease itself, not the loss of the limb, drives most of that mortality risk. The systemic nature of atherosclerosis means that people who have lost enough blood flow to need an amputation typically have significant blockages elsewhere, particularly in the arteries supplying the heart and brain. This is why early detection and aggressive risk factor management matter so much. Catching PVD at the claudication stage and addressing smoking, blood sugar, cholesterol, and blood pressure can slow progression and dramatically reduce the chance of reaching the point where limb loss or cardiovascular events become likely.